Glaucoma Medical Therapy — Principles and Management

Glaucoma medical therapy has evolved with the advent of each new drug. This evolution has moved quickly and generated new information that clinicians need to understand, synthesize, and implement about medications that have specific benefits and risks for their glaucoma patients. This book aims to provide clinicians with an accessible guide to the current art and science of using clinically available drugs for the medical therapy of glaucoma. The contributors have attempted to present evidence-based information, while providing perspective from their clinical experience. In order to reflect the extensive changes that have occurred since the publication of the first edition in 1999, new chapters have been added about fixed combination drugs and the medical treatment of pediatric patients, and existing chapters have been thoroughly revised and updated. Glaucoma Medical Therapy will be a valuable reference for ophthalmologists in both practice and training, as well as for other practitioners who have clinical contact with glaucoma patients.

Peter A. Netland, MD, PhD is currently Siegal Professor, Director of Glaucoma, and Vice-Chair for Academic Affairs in the Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center. Dr. Netland is an internationally recognized expert in the clinical management of glaucoma.